The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Robyn Lynne Ward

Department of Medical Oncology

St. Vincent's Hospital

Sydney

New South Wales

Australia

[email]@*.unsw.edu.au

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Medical Oncology, St. Vincent's Hospital, Sydney, New South Wales, Australia. 1998 - 2005
  • St Vincent's Hospital, Victoria Street, Darlinghurst, NSW 2010. 2002
  • School of Medical Science, University of NSW, Sydney, Australia. 2002
  • Cooperative Research Centre for Biopharmaceutical Research Ltd., Darlinghurst, New South Wales, Australia. 2000

References

  1. Routine testing for mismatch repair deficiency in sporadic colorectal cancer is justified. Ward, R.L., Turner, J., Williams, R., Pekarsky, B., Packham, D., Velickovic, M., Meagher, A., O'Connor, T., Hawkins, N.J. J. Pathol. (2005) [Pubmed]
  2. The CpG island methylator phenotype is not associated with a personal or family history of cancer. Ward, R.L., Williams, R., Law, M., Hawkins, N.J. Cancer Res. (2004) [Pubmed]
  3. Adverse prognostic effect of methylation in colorectal cancer is reversed by microsatellite instability. Ward, R.L., Cheong, K., Ku, S.L., Meagher, A., O'Connor, T., Hawkins, N.J. J. Clin. Oncol. (2003) [Pubmed]
  4. Medical oncology. Ward, R.L., Hawkins, N.J. Med. J. Aust. (2002) [Pubmed]
  5. Impact of microsatellite testing and mismatch repair protein expression on the clinical interpretation of genetic testing in hereditary non-polyposis colorectal cancer. Ward, R., Meldrum, C., Williams, R., Mokany, E., Scott, R., Turner, J., Hawkins, N., Burgess, B., Groombridge, C., Spigelman, A. J. Cancer Res. Clin. Oncol. (2002) [Pubmed]
  6. Microsatellite instability and the clinicopathological features of sporadic colorectal cancer. Ward, R., Meagher, A., Tomlinson, I., O'Connor, T., Norrie, M., Wu, R., Hawkins, N. Gut (2001) [Pubmed]
  7. Checking the scoreboard: the impact of cancer genetics on clinical practice. Ward, R.L., Hawkins, N.J. Intern. Med. J (2001) [Pubmed]
  8. Factors influencing the detection of mutant K-ras in the serum of patients with colorectal cancer. Ward, R., Sheehan, C., Norrie, M., Applegate, T., Fuery, C., Impey, H., Hawkins, N., Todd, A. Ann. N. Y. Acad. Sci. (2000) [Pubmed]
  9. Phase I clinical trial of the chimeric monoclonal antibody (c30.6) in patients with metastatic colorectal cancer. Ward, R.L., Packham, D., Smythe, A.M., Murray, J., Anderson-Stewart, P., Kitchen, N., Muirhead, R., Phillips, P., Gray, P., Bigg-Wither, G., Prabakaran, K., Freund, J., Fullham, M., Rule, M., Dalley, D., Meagher, A., Hawkins, N.J., Smith, G.M. Clin. Cancer Res. (2000) [Pubmed]
  10. Restriction endonuclease-mediated selective polymerase chain reaction: a novel assay for the detection of K-ras mutations in clinical samples. Ward, R., Hawkins, N., O'Grady, R., Sheehan, C., O'Connor, T., Impey, H., Roberts, N., Fuery, C., Todd, A. Am. J. Pathol. (1998) [Pubmed]
 
WikiGenes - Universities